The experimental drug Bremelanotide (formerly PT-141) does not act on the vascular system like the former compounds but increases sexual desire and drive in male as well as female. It is applied as a nasal spray. Bremelanotide works by activating melanocortin receptors in the brain. It is currently in Phase IIb trials. super sales of viagra online Buy viagra online canada buy viagra c.o.d viagra pills sale online order order phentermine viagra viagra online canadian pharmacy buy viagra online viagra buy to viagra where viagra for sale viagra in canada viagra pills for sale viagra sample pack check buy viagra canadian pharmacy free viagra order online viagra online canadian pharmacy online viagra viagra The study authors focused on 12 patients who had been diagnosed with chronic obstructive pulmonary disease and were suspected of having PAH. Throughout the study, right heart blood pressure was tracked among all 12 patients by inserting a thin plastic tube into the pulmonary artery -- a procedure known as cardiac catheterization. Cardiac blood pressure was measured at rest and just after all the patients cycled for three minutes. discounted viagra for sale viagra online buy viagra viagra online viagra genericviagra online Yohimbine improves erections for a small percentage of men. It stimulates the parasympathetic nervous system, which is linked to erection, and may increase libido. It is necessary to take the medication for 6 to 8 weeks before determining whether it will work or not. Second, an undescended testicle is more likely to develop a tumor. Testicular cancer affects one of every 2,000 men with undescended testicles. This rate of testicular cancer is higher than the rate in men whose testicles have dropped naturally. When the testicle is inside the scrotum, a man can easily feel his testicles to check for a tumor, or he can be checked by his doctor. This way, any tumor can be found early, when the cancer is easier to cure. Forget Viagra! Sound waves can send your sex life into orbit best price viagra viagra
 
 
Show background image
Tuesday, 29 July 2014

Cool Pictures

Shirini Yazdi

Home  >  Media  >  News Release

New technique helps determine degree of muscle wasting in critically ill patients

Vienna, Austria: Researchers have identified a new technique that can help determine the severity of muscle loss in critically ill patients. The breakthrough could lead to new research to help prevent muscle-wasting and new therapeutic interventions to help treat critically ill patients.

 

The results of the study will be presented today (2 September 2012) at the European Respiratory Society’s Annual Congress in Vienna.

 

Patients who are critically ill with multi-organ failure often have significant muscle wasting after recovering from their illness. This can delay their discharge from an intensive care unit and is a major cause of disability affecting quality of life once patients have left the hospital.

 

Until now, there has been no clinically useful way of measuring muscle wastage, or identifying patients who are at a high-risk of this. The researchers hypothesised that they could measure the rectus femoris, one of the four quadriceps muscles in the leg, to determine the level of muscle wasting.

 

63 patients were recruited to the study within 24 hours of admission to hospital. Muscle wasting was assessed using an ultrasound to measure muscle circumference of the rectus femoris. Researchers also monitored the number of failed organ systems during the patient’s time in intensive care, to assess which patients were at a high risk of muscle wasting.

 

The researchers determined that circumference measurements of the rectus femoris area by ultra sound can objectively track muscle loss early in critical illness. They also determined that the greatest reduction in muscle circumference was seen in patients with multi-organ failure. In patients with multi-organ failure, the circumference of the rectus femoris was reduced by approximately 21.53%. This compared with an approximate reduction of 7.2% in people with single organ failure.

 

Lead author, Dr Zudin Puthucheary from University College London, UK, said: “Our research has determined that measuring the rectus femoris using ultrasound is a useful tool to analyse the degree of muscle wasting in critically ill patients. This is clinically relevant as it can help healthcare professionals detect those at high-risk of muscle loss and provide interventions to help improve their quality of life. It is also an important discovery for research as it can help scientists track muscle response to different interventions, so we can find new solutions to addressing this problem in our critically ill patients.”

 

Notes to editors:

  • Abstract: Severity of acute critical illness determines degree of muscle wasting
  • Session: 74
  • Date and time: Sunday 2 September, 10:45-12:45
  • Room: Lehar 3-4

     

Press Office at ERS Congress in Vienna (Saturday 31st August - Wednesday 5th September 2012):

Lauren Anderson: +43 6763315356   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

David Sadler: +43 6767502294

Abstract Print Zone

Browse the electronic book online, print the selected pages or download the full abstract book.

Access it now